Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Byetta vs Symlin in Type 1 Diabetes
NCT01269047Phase 4Completed
- Sponsor
- Albert Einstein College of Medicine
- Start
- Aug 2009
- Primary completion
- Aug 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of exenatide, pramlintide in type 1 diabetes mellitus (T1D), sponsored by Albert Einstein College of Medicine. Started Aug 2009; status: completed.
02
Drugs
exenatidepramlintide
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01269047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01269047.